Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $60.30, signifying a +1.88% move from its prior day's close.

Analysts at Zacks Research raised their Q1 2025 EPS estimates for shares of Interactive Brokers Group in a research note ...

The most recent trading session ended with Synopsys (SNPS) standing at $522.53, reflecting a -1.09% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a ...

Equities research analysts at Zacks Research raised their Q2 2025 EPS estimates for shares of Synchrony Financial in a ...

Bio-Rad Laboratories, Inc. BIO posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.90, which missed the Zacks ...

Ceragon Networks Ltd. CRNT recently reported fourth-quarter 2024 adjusted earnings per share (EPS) of 9 cents, which missed ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Zydus Lifesciences Ltd on Friday announced that the United States Food and Drug Administration (USFDA) has completed an inspection at its facility in Ahmedabad with nil observations. – Net Profit Up ...